U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722910) titled 'Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma' on July 20.
Brief Summary: The goal of this observational study is to quantify iris blood flow via non-invasive eye scanning for evaluating ocular lesions in adults aged 18 years and older, including healthy volunteers, patients with type 2 diabetes mellitus (T2DM) without fundus lesions, T2DM patients with diabetic retinopathy (DR), and T2DM patients complicated with both DR and neovascular glaucoma (NVG). The main questions it aims to answer are:
* Does iris blood flow fraction at six pupillary quadrants differ significantly among people with different stag...